Core Insights - Safety Shot, Inc. anticipates a 1000% increase in annual revenue for 2025 compared to 2024 following the acquisition of Yerbae Brands Corp. [1] - The acquisition is expected to enhance Safety Shot's market position by leveraging Yerbae's retail presence, distributor network, and innovative product offerings [1][2]. Retail Expansion - Yerbae has established a strong retail presence, including partnerships with North America's largest club store retailer, Kroger, and Sprouts Farmers Market, which will contribute to Safety Shot's growth [2][3][4]. - Yerbae's products are now authorized in over 1,200 Kroger locations across 22 states, with significant placements expected to increase in 2025 [3]. - Sprouts Farmers Market is expanding Yerbae's portfolio with a new SKU across 419 stores, following a 45.2% dollar growth in the previous year [4]. Distribution Network - Yerbae's distribution network is expanding through partnerships with various distributors, enhancing its reach in the Caribbean and West Coast ports [10]. - The company has secured placements in over 340 national accounts, including major corporations like Google and Spotify, further broadening its market access [15]. Product Innovation - Safety Shot's flagship product, Sure Shot, is a patented wellness product designed to lower blood alcohol content while enhancing clarity and energy [11]. - Yerbae's beverages are marketed as zero calorie, zero sugar, and non-GMO, appealing to health-conscious consumers [12][13].

Business Acquisition and Product Development - Safety Shot Inc. completed the asset purchase of the Sure Shot Dietary Supplement in August 2023, gaining ownership of various assets including intellectual property and trademarks [124]. - The Sure Shot Dietary Supplement is formulated to reduce blood alcohol content and contains 28 active ingredients classified as Generally Regarded As Safe (GRAS) [125]. - The product was launched in December 2023 through the company's website, Amazon, and several Big Box stores, with plans for new flavors and formats [128]. - The Company owns five patents related to the Sure Shot Dietary Supplement, with the most recent patent expiring on November 5, 2035 [149]. - All ingredients in the Sure Shot Dietary Supplement are deemed Generally Recognized as Safe (GRAS) and comply with FDA standards [155]. - The Company is committed to continuous innovation and has built a substantial portfolio of intellectual property to address unmet market needs [135]. Financial Performance - The Company reported a net loss of $5,326,933 for the three months ended March 31, 2025, compared to a net loss of $15,674,671 for the same period in 2024 [165]. - The Company generated $42,101 in revenues for the three months ended March 31, 2025, a decrease of 75.3% compared to $170,732 in the same period of 2024 [187]. - Cost of sales for the three months ended March 31, 2025 was $21,112, significantly lower than $2,383,285 for the same period in 2024 [186]. - Total operating expenses decreased to $5,411,325 for the three months ended March 31, 2025, compared to $12,956,552 for the same period in 2024, reflecting a reduction of approximately 58% [188]. - The Company incurred research and development expenses of $9,005 for the three months ended March 31, 2025, down from $141,493 in the same period of 2024 [176]. - Stock-based compensation for the three months ended March 31, 2025 was $1,985,376, a significant decrease from $8,090,534 in the same period of 2024 [189]. - The Company reported other income of $63,402 for the three months ended March 31, 2025, compared to an expense of $505,566 in the same period of 2024 [186]. - Net loss for the three months ended March 31, 2025 was $5,326,933, a reduction of 66% compared to a net loss of $15,674,671 for the same period in 2024 [193]. Research and Development - Research and development expenses increased from $100,591 in 2022 to $1,637,117 in 2023, reflecting ongoing efforts to enhance existing products and develop new therapeutic options [132]. - Clinical trials conducted from January 29, 2024, to June 10, 2024, showed a statistically significant reduction in Blood Alcohol Content (BAC) with a p-value of 0.002 [131]. Regulatory and Compliance - The Company is subject to various U.S. federal, state, and local regulations affecting the production and sale of its dietary supplement products [150]. - The Company is classified as an "emerging growth company," allowing it to take advantage of certain exemptions from reporting requirements [160]. Investment and Financing - A settlement agreement with Bigger Capital was reached on January 20, 2025, involving a payment of $375,000 and the issuance of convertible notes totaling $5.25 million [136]. - The Secured Convertible Bigger Note has a 9% annual interest rate and can be converted into shares of common stock at a conversion price of $0.5435 or the market price [137][139]. - The Company is engaged in a Liabilities Settlement Program with Silverback Capital Corporation, involving an initial claim amount of $14,580,395.73 [147]. Operational Strategy - The company primarily sells products through e-commerce platforms, focusing on customer experience and brand promotion to drive growth [133]. - Manufacturing is outsourced to contract manufacturers in India and the US, with products shipped to third-party warehouses for distribution [134]. - The Company redirected its focus on the acquisition of Yerbae Brands Inc. and plans to implement a new marketing strategy in the second quarter of 2025 [187]. Shareholder Information - The weighted-average number of common shares outstanding increased to 69,258,402 in Q1 2025 from 47,435,503 in Q1 2024 [165]. - Basic and diluted loss per share for Q1 2025 was $0.08, compared to $0.33 for Q1 2024 [166]. - The Company has not recorded any cash equivalents as of March 31, 2025, or December 31, 2024 [163]. - The Company utilizes the equity method for investments in unconsolidated affiliates, reporting profits and losses in its financial statements [157]. - Deferred tax assets as of March 31, 2025 were approximately $15,362,309, fully offset by a valuation allowance due to the lack of earnings history [175].

Core Viewpoint - Safety Shot, Inc. has postponed the record date for the spin-off and distribution of shares of Caring Brands, Inc. due to the lack of approval from Nasdaq for the listing of Caring Brands Common Stock [1][3]. Group 1: Spin-off Details - The new record date for the distribution of Caring Brands Common Stock will be announced later, with stockholders receiving one share for every 45 shares of Safety Shot's common stock held [2]. - Fractional shares of Caring Brands Common Stock will not be distributed; instead, they will be rounded down to whole shares by the distribution agent, ClearTrust, LLC [2]. - The distribution was initially expected to occur around August 9, 2025, contingent upon the effectiveness of Caring Brands' Registration Statement and Nasdaq's approval [3]. Group 2: Company Overview - Safety Shot, Inc. is a wellness and dietary supplement company known for its product Sure Shot, which is designed to lower blood alcohol content while enhancing clarity, energy, and mood [5]. - The company plans to expand its business-to-business sales of Sure Shot to various distributors, retailers, restaurants, and bars throughout 2025 [5].

Core Points - BASF has launched the BASF Safety Scouts program to promote on-farm safety among the next generation of farmers, providing 2,000 free safety kits annually to farm families across Canada [1][2][3] - The program aims to foster a culture of safety in agricultural communities, reflecting BASF's commitment to safety and community support [2][4] - BASF collaborates with the Canadian Agricultural Safety Association (CASA) to enhance farm safety resources and initiatives, including the CASA Kids FarmSafe Week [4][5] Company Overview - BASF Canada Agricultural Solutions, headquartered in Calgary, employs over 625 individuals and operates three production facilities in Canada [7] - In 2024, BASF's Agricultural Solutions division generated sales of €9.8 billion, highlighting its significant role in the agricultural sector [8][9] - BASF Canada reported sales of $2.6 billion in 2024, indicating its strong market presence in North America [10] Commitment to Sustainability - BASF emphasizes the integration of sustainability criteria into its business decisions, investing €919 million in R&D in 2024 to support sustainable agricultural practices [8] - The company aims to provide innovative solutions that connect various agricultural products and services to enhance outcomes for farmers and stakeholders [8]

Core Insights - Safety Shot, Inc. has experienced significant growth and product demand following the launch of its Sure Shot product on Amazon and its own e-commerce site, with both platforms selling out quickly [2][3] - The company has conducted a successful clinical trial demonstrating that Sure Shot effectively reduces blood alcohol concentration and alleviates hangover symptoms, reinforcing its market position [3][7] - Safety Shot is expanding its distribution through partnerships with major retailers, enhancing accessibility and brand recognition [5][9] Product Launch and Market Response - The launch of Sure Shot on Amazon in November 2023 generated high demand, leading to a sell-out within hours, followed by a similar response on the company's e-commerce site in January 2024 [2] - The rebranding to Sure Shot and the introduction of a 4 oz. package aim to enhance consumer convenience while maintaining quality [4] Clinical Validation - Positive results from a peer-reviewed clinical trial indicate that Sure Shot significantly mitigates the negative effects of alcohol consumption, with statistical significance (p < 0.05) [3] Strategic Partnerships - Safety Shot is actively pursuing partnerships with retailers such as Walmart.com, Albertson's, and GoPuff to expand its market presence and drive sales [5] Spin-Off and Shareholder Value - The company plans to spin off its Caring Brands division, distributing 2 million shares to Safety Shot shareholders to unlock value and foster growth [6] Intellectual Property - A new patent has been secured to protect Safety Shot's innovations and support its clinically backed claims, positioning the company as a leader in the dietary supplement industry [7] Future Growth Prospects - The acquisition of Yerbae is anticipated to significantly expand Safety Shot's product offerings and distribution channels, with a shareholder meeting planned for late May/June to finalize the acquisition [9] - The company is shifting its marketing strategy to focus on grassroots efforts and partnerships, moving away from influencer-centric marketing to enhance product accessibility [11]

Core Viewpoint - Safety Shot, Inc. is set to spin off its subsidiary, Caring Brands, Inc., with a record date for the distribution of shares established for April 7, 2025 [1][2]. Group 1: Spin-off Details - Stockholders will receive one share of Caring Brands Common Stock for every 45 shares of Safety Shot's common stock held as of the record date [2]. - Fractional shares of Caring Brands Common Stock will not be distributed; instead, they will be rounded down to whole shares [2]. - The distribution is expected to occur around August 9, 2025, contingent upon the effectiveness of Caring Brands' Registration Statement and other necessary approvals [3]. Group 2: Trading and Regulatory Aspects - Caring Brands Common Stock is anticipated to begin trading on Nasdaq on or about April 11, 2025, pending regulatory approvals [3]. - The Registration Statement for Caring Brands Common Stock has been filed with the SEC but is not yet effective, meaning shares cannot be sold or offered until it becomes effective [4]. Group 3: Company Overview - Safety Shot, Inc. specializes in wellness and dietary supplements, with its flagship product, Sure Shot, designed to lower blood alcohol content while enhancing clarity and mood [5]. - The company plans to expand its business-to-business sales of Sure Shot to various distributors and retailers throughout 2025 [5].

Financial Performance - Safety Shot Inc. reported a net loss of $51.7 million for the year ended December 31, 2024, compared to a net loss of $15.1 million for 2023, reflecting an increase in losses of 243%[252] - The Company generated revenues of $701,967 for the year ended December 31, 2024, compared to $202,670 for the year ended December 31, 2023, reflecting an increase due to the commencement of marketing and selling its Safety Shot beverage in December 2023[267] - Total operating expenses for the year ended December 31, 2024, were $39,611,915, significantly higher than $12,524,869 for the year ended December 31, 2023[268] - The net loss from continuing operations was $48,411,830 for the year ended December 31, 2024, compared to $14,821,513 for the year ended December 31, 2023[266] - The Company had a gross profit (loss) of $(2,445,757) for the year ended December 31, 2024, compared to $(74,457) for the year ended December 31, 2023[266] - Losses from discontinued operations were $997,802 for the year ended December 31, 2024, compared to $261,528 for the year ended December 31, 2023[273] - Other income for the year ended December 31, 2024, included realized gains of $1,193,666 on the sale of marketable securities[271] - The Company incurred a deemed dividend of $2,293,301 related to the settlement with Bigger Capital, which is considered in the determination of earnings per share[275] Product Development and Strategy - The company launched its e-commerce sales of the Safety Shot Beverage in December 2023, following the acquisition of the product and related assets in August 2023[230] - The Safety Shot Beverage is formulated with 28 active ingredients and is manufactured in a facility adhering to Good Manufacturing Practices (GMP)[231][233] - The company plans to relaunch its Photocil product in the U.S. in Q4 2024 after receiving FDA approval, with current sales occurring in India through a licensing agreement[237] - Safety Shot Inc. is focusing on expanding its product line, including a powdered stick pack version of the Safety Shot Beverage, while discontinuing its CBD product offerings[234][239] - The Company is in commercialization mode while continuing to pursue the development of next-generation products and new products[277] Operational Efficiency - The weighted average number of common shares outstanding increased from 30.9 million in 2023 to 54.4 million in 2024, impacting the loss per share calculation[252] - The company maintains a diverse network of raw material suppliers, ensuring high-quality production for its beverage and other health products[238] - Safety Shot Inc. does not experience concentration risk or dependence on major customers, indicating a stable revenue generation strategy[237] - The company has not recognized any allowance for doubtful collections during the years ended December 31, 2024, and 2023, indicating effective receivables management[255] Financial Position - The deferred tax asset at December 31, 2024, was $14,660,582, fully offset by a valuation allowance due to the Company's lack of earnings history[259] - Research and development expenses amounted to $271,719 for the year ended December 31, 2024, compared to $100,591 for the year ended December 31, 2023[260] - The company aims to partner with industry leaders to access the latest technologies and expand its market reach[236]

Core Viewpoint - Safety Shot, Inc. is set to spin off its subsidiary, Caring Brands, Inc., with a record date for the distribution of shares established for April 7, 2025 [1][2]. Group 1: Spin-off Details - Stockholders will receive one share of Caring Brands Common Stock for every 45 shares of Safety Shot's common stock held as of the Record Date [2]. - Fractional shares of Caring Brands Common Stock will not be distributed; instead, they will be rounded down to whole shares by the distribution agent, ClearTrust, LLC [2]. - The distribution is expected to occur around August 9, 2025, contingent upon the effectiveness of Caring Brands' Registration Statement and other necessary approvals [3]. Group 2: Trading and Regulatory Aspects - Caring Brands Common Stock is anticipated to begin trading on Nasdaq around April 11, 2025, provided all regulatory approvals are secured [3]. - The Registration Statement for Caring Brands Common Stock has been filed with the SEC but is not yet effective, meaning shares cannot be sold or offered until it becomes effective [4]. Group 3: Company Overview - Safety Shot, Inc. specializes in wellness and dietary supplements, with its flagship product, Sure Shot, designed to lower blood alcohol content while enhancing clarity, energy, and mood [5]. - The company plans to expand its business-to-business sales of Sure Shot to various distributors and retailers throughout 2025 [5].

Core Insights - Safety Shot, Inc. has published a peer-reviewed study demonstrating that its product significantly reduces blood alcohol concentration (BAC), breath alcohol concentration (BrAC), and hangover symptoms compared to a placebo, indicating its potential utility in managing alcohol consumption effects [1][2][3] Study Details - The clinical trial was conducted by The Center for Applied Health Sciences (CAHS) and involved a diverse group of healthy participants who consumed alcohol followed by either Safety Shot or a placebo in a crossover design [2][5] - The study employed a rigorous double-blind, randomized, placebo-controlled design to ensure scientific accuracy and minimize variability among participants [2] Key Findings - Safety Shot reduced blood alcohol levels within 30 minutes, showing statistically significant reductions in both blood and breath alcohol levels over a period of 30 to 240 minutes post-consumption [4] - The product significantly increased aldehyde dehydrogenase levels, suggesting an enhanced metabolic response to alcohol elimination [4] - Participants reported improved hangover symptoms, including less head discomfort, reduced fatigue, and increased energy levels compared to the placebo group [4] - Increased urine output was observed in participants taking Safety Shot, indicating enhanced elimination of alcohol from the body [4] Market Potential - The global market for hangover cure products is projected to grow at a compound annual growth rate (CAGR) of 14.1% from 2023 to 2030, potentially exceeding $6 billion by 2032, driven by rising alcohol consumption and demand for effective solutions [6] - Safety Shot is strategically positioned to capture a significant share of this expanding market due to its clinically proven efficacy and unique human-based research [6] Company Overview - Safety Shot, Inc. has developed Sure Shot, a patented wellness product designed to lower blood alcohol content while enhancing clarity, energy, and overall mood [7] - The product is available for purchase online and the company plans to introduce business-to-business sales to various distributors and retailers throughout 2025 [7] - Sure Shot contains a proprietary blend of natural ingredients aimed at supporting the body's detoxification processes and promoting overall wellness [7]

Core Insights - Safety Shot, Inc. has appointed CORE IR & PR to enhance its investor relations and public communications as part of its strategic growth initiatives [1][2] - The partnership aims to increase market awareness of Safety Shot's business model and growth strategies among institutional and retail investors [2][3] - CORE IR specializes in investor engagement and public relations, particularly in the healthcare and retail sectors, which aligns with Safety Shot's market focus [3] Company Overview - Safety Shot, Inc. is a wellness and dietary supplement company known for its product Sure Shot, which is designed to lower blood alcohol content while enhancing clarity, energy, and mood [4] - Sure Shot is available for purchase online through various platforms, including its own website, Walmart, and Amazon, and the company plans to expand its business-to-business sales throughout 2025 [4]